A Prehospital Decision Support Tool for the Diagnosis of Acute Heart Failure: The RAPID-CHF Score.

IF 10.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Jennifer Y Zhou, Jocasta Ball, Emily Nehme, David Anderson, Emily Mahony, Tegwyn McManamny, Jesslyn Wijaya, Shane Nanayakkara, David M Kaye, Ziad Nehme, Dion Stub
{"title":"A Prehospital Decision Support Tool for the Diagnosis of Acute Heart Failure: The RAPID-CHF Score.","authors":"Jennifer Y Zhou, Jocasta Ball, Emily Nehme, David Anderson, Emily Mahony, Tegwyn McManamny, Jesslyn Wijaya, Shane Nanayakkara, David M Kaye, Ziad Nehme, Dion Stub","doi":"10.1093/ejhf/xuag138","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Diagnostic uncertainty is a major barrier to the timely treatment of heart failure (HF) in the prehospital setting. We aimed to develop and validate a decision support tool using readily available clinical variables to predict the probability of HF among dyspnoeic patients transported by emergency medical services (EMS).</p><p><strong>Methods and results: </strong>A population-based cohort of all adults transported by EMS for dyspnoea in Victoria, Australia was chronologically split into derivation (2015-2017) and temporal validation (2018-2019) cohorts. Two models were developed: (1) a full multivariable logistic regression model using adaptive least absolute shrinkage and selection operator regression, and (2) a simplified points-based RAPID-CHF score derived from the nine most predictive variables. Among 271,204 patients with dyspnoea (176,269 derivation; 94,935 validation), 9.4% and 9.0% had HF, respectively. The full model included 19 variables and demonstrated excellent discrimination (AUC 0.861 derivation; 0.862 validation) and calibration. The RAPID-CHF score (range 0-13; comprising age, ECG rhythm, prior HF, conscious state, oxygen saturation, blood pressure, temperature, peripheral oedema, and crackles) retained strong performance (AUC 0.835 derivation; 0.836 validation) and calibration. HF prevalence increased across predefined risk categories: low (score 0-5; HF prevalence 1.7%), moderate (6-9; 13.6%) and high (10-13; 46.4%). Decision curve analysis demonstrated greater net benefit across clinically relevant thresholds than current EMS diagnosis or \"treat all\"/\"treat none\" strategies.</p><p><strong>Conclusion: </strong>A risk score derived from routinely collected prehospital variables accurately estimates HF probability among EMS-transported patients with dyspnoea. The RAPID-CHF score may facilitate earlier diagnosis and timely initiation of HF therapy in EMS workflows.</p>","PeriodicalId":164,"journal":{"name":"European Journal of Heart Failure","volume":" ","pages":""},"PeriodicalIF":10.8000,"publicationDate":"2026-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ejhf/xuag138","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: Diagnostic uncertainty is a major barrier to the timely treatment of heart failure (HF) in the prehospital setting. We aimed to develop and validate a decision support tool using readily available clinical variables to predict the probability of HF among dyspnoeic patients transported by emergency medical services (EMS).

Methods and results: A population-based cohort of all adults transported by EMS for dyspnoea in Victoria, Australia was chronologically split into derivation (2015-2017) and temporal validation (2018-2019) cohorts. Two models were developed: (1) a full multivariable logistic regression model using adaptive least absolute shrinkage and selection operator regression, and (2) a simplified points-based RAPID-CHF score derived from the nine most predictive variables. Among 271,204 patients with dyspnoea (176,269 derivation; 94,935 validation), 9.4% and 9.0% had HF, respectively. The full model included 19 variables and demonstrated excellent discrimination (AUC 0.861 derivation; 0.862 validation) and calibration. The RAPID-CHF score (range 0-13; comprising age, ECG rhythm, prior HF, conscious state, oxygen saturation, blood pressure, temperature, peripheral oedema, and crackles) retained strong performance (AUC 0.835 derivation; 0.836 validation) and calibration. HF prevalence increased across predefined risk categories: low (score 0-5; HF prevalence 1.7%), moderate (6-9; 13.6%) and high (10-13; 46.4%). Decision curve analysis demonstrated greater net benefit across clinically relevant thresholds than current EMS diagnosis or "treat all"/"treat none" strategies.

Conclusion: A risk score derived from routinely collected prehospital variables accurately estimates HF probability among EMS-transported patients with dyspnoea. The RAPID-CHF score may facilitate earlier diagnosis and timely initiation of HF therapy in EMS workflows.

诊断急性心力衰竭的院前决策支持工具:RAPID-CHF评分
目的:诊断不确定性是院前及时治疗心力衰竭(HF)的主要障碍。我们的目的是开发和验证一个决策支持工具,使用现成的临床变量来预测急诊医疗服务(EMS)运送的呼吸困难患者发生HF的概率。方法和结果:一个基于人群的队列,包括澳大利亚维多利亚州所有因呼吸困难而被EMS运送的成年人,按时间顺序分为衍生队列(2015-2017)和时间验证队列(2018-2019)。建立了两个模型:(1)使用自适应最小绝对收缩和选择算子回归的全多变量逻辑回归模型;(2)基于9个最具预测性变量的简化的基于点的RAPID-CHF评分。在271204例呼吸困难患者中(衍生176269例,验证94935例),分别有9.4%和9.0%的HF。完整模型包含19个变量,具有良好的判别性(推导AUC为0.861,验证AUC为0.862)和校准。RAPID-CHF评分(范围0-13,包括年龄、心电节律、既往心衰、意识状态、血氧饱和度、血压、体温、外周水肿和破裂)保持了较强的性能(AUC推导值0.835,验证值0.836)和校准。HF患病率在预定义的风险类别中有所增加:低(得分0-5;HF患病率1.7%)、中(得分6-9;13.6%)和高(得分10-13;46.4%)。决策曲线分析显示,与目前的EMS诊断或“全部治疗”/“不治疗”策略相比,在临床相关阈值上的净收益更高。结论:从常规收集的院前变量中得出的风险评分准确地估计了ems转运的呼吸困难患者发生HF的可能性。在EMS工作流程中,RAPID-CHF评分可以促进早期诊断和及时开始HF治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Journal of Heart Failure
European Journal of Heart Failure 医学-心血管系统
CiteScore
27.30
自引率
11.50%
发文量
365
审稿时长
1 months
期刊介绍: European Journal of Heart Failure is an international journal dedicated to advancing knowledge in the field of heart failure management. The journal publishes reviews and editorials aimed at improving understanding, prevention, investigation, and treatment of heart failure. It covers various disciplines such as molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, clinical sciences, social sciences, and population sciences. The journal welcomes submissions of manuscripts on basic, clinical, and population sciences, as well as original contributions on nursing, care of the elderly, primary care, health economics, and other related specialist fields. It is published monthly and has a readership that includes cardiologists, emergency room physicians, intensivists, internists, general physicians, cardiac nurses, diabetologists, epidemiologists, basic scientists focusing on cardiovascular research, and those working in rehabilitation. The journal is abstracted and indexed in various databases such as Academic Search, Embase, MEDLINE/PubMed, and Science Citation Index.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书